Human immunodeficiency virus - Advanced Topics History and Comparative Virology

HIV: Origins, Evolution, and Transmission Introduction Understanding HIV begins with recognizing it as a relatively recent human pathogen with roots in other primate species. The virus exhibits multiple genetic variants, spreads through both traditional and novel cellular mechanisms, and can persist in the body despite drug treatment. This section covers the origins of HIV, how it relates to natural primate viruses, and the cellular mechanisms that allow it to evade immune control. Part 1: HIV Origins and Global Distribution Zoonotic Origins: The Chimpanzee Connection HIV-1, the most common form of HIV globally, did not originate in humans. Instead, it jumped from chimpanzees (Pan troglodytes troglodytes) to humans through cross-species transmission, likely during hunting or butchering of infected animals. This process, called zoonotic transmission, introduced a primate virus into the human population. The key point: HIV-1 is a recent evolutionary derivative of simian immunodeficiency virus (SIV) found in chimpanzees. Understanding this zoonotic origin explains why studying natural SIV infection in other primates provides crucial insights into how HIV might be controlled. HIV-1 Genetic Subtypes: Not One Virus, But Many Once HIV-1 entered humans, it did not remain uniform. Global sequencing studies identified distinct HIV-1 subtypes—genetic variants that differ in their sequence by roughly 10-15% at the DNA level. These subtypes, labeled A through K, emerged as the virus spread through different populations worldwide. Additionally, as different subtypes circulated in the same people, they recombined to form circulating recombinant forms (CRFs). This genetic diversity has profound implications: Vaccine design becomes challenging because a vaccine effective against one subtype may not protect against another Drug resistance patterns vary between subtypes Transmission efficiency differs depending on the viral variant and host factors This is not simply an academic curiosity—it directly affects how we treat and prevent HIV globally. Early Epidemic Spread: The Kinshasa Evidence One of the most important clues to understanding HIV's emergence comes from studying ancient viral sequences. Researchers analyzed archival blood samples from Kinshasa, Congo, collected in the 1960s, and found multiple distinct HIV-1 variants already present. This genetic diversity at such an early point indicates rapid viral diversification, suggesting that HIV must have begun spreading in Central Africa sometime before 1960, probably decades earlier. How Human Behavior Accelerated HIV Transmission The early spread of HIV was not random. Three key behavioral and technological factors amplified transmission: Urban migration created dense populations of new migrants in cities like Kinshasa, where existing social networks were disrupted and sexual partnerships more fluid. Commercial sex work provided a transmission bridge between geographically distant individuals, allowing the virus to spread far more rapidly than it would have in isolated communities. Mass-produced syringes introduced in the 1950s, paradoxically, may have amplified transmission in medical settings and among people who injected drugs. Before mass-produced needles, traditional methods of reuse were less frequent and less efficient at transmitting bloodborne pathogens. These factors explain why HIV, despite likely existing for decades before 1960, suddenly exploded into a global pandemic in the 1980s. Part 2: SIV in Natural Hosts—A Crucial Comparison The Paradox: High Viral Load Without Disease Here is one of the most important and counterintuitive facts about primate immunodeficiency viruses: Natural SIV-infected animals, particularly African green monkeys, maintain extremely high viral loads yet do not develop AIDS. An infected African green monkey can harbor viral loads of 10⁶ to 10⁷ viral particles per milliliter of blood—levels comparable to or even exceeding those seen in untreated humans with AIDS. Yet the monkey remains healthy. This reveals a fundamental truth: viral load alone does not cause AIDS. Something else about the host response differs between natural SIV hosts and HIV-infected humans. Why Natural Hosts Avoid AIDS: Immune Activation Is Key The difference lies not in viral control but in immune activation. When humans contract HIV, their immune system launches a powerful but ultimately futile response. This chronic immune activation—reflected in elevated levels of inflammatory markers, activated T cells, and immune exhaustion—directly damages the immune system itself. Paradoxically, fighting the virus damages the immune system more than the virus alone would. Natural SIV hosts evolved mechanisms to maintain calm immune responses despite high viral loads. They limit immune activation, preserve regulatory T cell function, and avoid the chronic inflammation that drives AIDS pathology. This represents a form of evolutionary accommodation rather than viral control—the host lives peacefully with high levels of virus. Why this matters for your exam: This comparison shows that understanding AIDS requires understanding the immune response, not just viral biology. It also motivates vaccine and therapeutic research aiming to shift human immune responses toward the "tolerant" mode seen in natural hosts. Extensive Genetic Variability in SIV SIV exists in multiple forms across different African primate species (chimpanzees, macaques, sooty mangabeys, African green monkeys, etc.), and within each species, extensive genetic variation exists. This natural reservoir of viral diversity is essentially a laboratory for studying lentiviral evolution. Understanding how SIV adapts within primates informs us about how HIV does the same in humans. Part 3: Cell-to-Cell Transmission of HIV This section covers transmission mechanisms that are easy to overlook but critically important for understanding HIV persistence and drug resistance. Two Paths of Viral Spread: Cell-Free and Cell-to-Cell Most students learn that HIV spreads by budding from an infected cell, entering the bloodstream as free virus particles, and infecting distant target cells. This cell-free transmission is real, but it is not the complete story. HIV also spreads directly from one cell to its neighbors through cell-to-cell transmission. In this mode, virus particles transfer directly across cellular contacts without entering the bloodstream. This distinction matters enormously because it affects drug efficacy and viral persistence. Virological Synapses: Specialized Contact Sites When an HIV-infected cell contacts a target CD4+ T cell, the two cells form specialized junction structures called virological synapses. These are HIV-specific cell-to-cell contact sites where: Viral particles accumulate at the junction The actin cytoskeleton of both cells reorganizes to stabilize the contact High concentrations of virus transfer directly into the target cell Think of a virological synapse as similar to a biological "handshake" optimized for viral delivery. The infected cell essentially projects virus directly into its neighbor, bypassing the extracellular space entirely. The Glycoprotein Activation Problem: Why Cleavage Matters For HIV to infect a cell, its outer glycoprotein coat must be precisely processed. The key step is cleavage of the precursor gp160 protein into its functional components gp120 and gp41 by an enzyme called furin. gp120 binds to CD4 and chemokine receptors on target cells gp41 mediates membrane fusion If furin-mediated cleavage is blocked, the gp160 remains uncleaved and the virus cannot activate. This is why furin inhibitors block HIV entry. However, in cell-to-cell transmission, viruses may partially bypass this requirement because the intimate cell-to-cell contact allows alternative fusion mechanisms. High-Multiplicity Transmission: Multiple Viruses, Multiple Problems In cell-free transmission, typically one virus particle infects one target cell (or sometimes none, due to dilution in the bloodstream). In contrast, during cell-to-cell transmission, especially when macrophages transfer virus to CD4+ T cells, multiple viral particles simultaneously enter the target cell in a process called high-multiplicity transmission. Why does this matter? Antiretroviral drugs work by blocking reverse transcriptase, integrase, or protease—enzymes needed to complete the viral life cycle. If a cell is infected with multiple viral particles: Some particles may carry drug-resistant mutations If one particle's replication is blocked by a drug, another may proceed unhindered The probability that at least one particle succeeds despite drug exposure increases dramatically This explains a crucial clinical observation: Cell-to-cell spread reduces antiretroviral drug efficacy because multiple viral genomes in one cell overcome single mutations conferring drug resistance. Viral Persistence Despite Therapy This cell-to-cell transmission mechanism has a troubling clinical consequence: HIV can continue replicating even when antiretroviral therapy suppresses cell-free virus to undetectable levels. Here's the scenario: Drugs successfully block cell-free virus production But infected macrophages and tissue reservoirs continue transferring virus to CD4+ T cells directly Cell-to-cell transmission, occurring in intimate tissue contacts, may partially evade drug exposure The virus persists in anatomically privileged sites like the central nervous system and lymphoid tissues This is why HIV is not "cured" by drugs alone—the virus adapts and persists through mechanisms that standard drugs cannot fully reach. Part 4: Clinical Perspectives—Early Recognition of AIDS Initial Presentations: Opportunistic Infections When AIDS first emerged in the 1980s, clinicians noticed a pattern: previously healthy, young adults presenting with rare infections. The most common early clinical presentations included: Pneumocystis pneumonia (PCP), caused by an organism that normally does not cause disease in healthy people Kaposi's sarcoma, a cancer caused by human herpesvirus 8, seen almost exclusively in severely immunosuppressed patients These infections were literally signals of immune collapse—they could only occur because CD4+ T cell counts had dropped below critical thresholds. The figure above shows the natural disease progression: after acute infection, CD4+ counts decline gradually over years until opportunistic infections and AIDS develop. Understanding this timeline is crucial for recognizing when a person needs treatment intensification or specific prophylaxis against opportunistic infections. <extrainfo> Historical Context Early AIDS cases were initially grouped among specific populations (gay men, injection drug users, Haitian immigrants, hemophiliacs), leading to the unfortunate acronym "GRID" (Gay-Related Immune Deficiency). This framing delayed understanding that AIDS was a communicable disease affecting any exposed person regardless of identity, until epidemiological work clarified the true transmission routes. </extrainfo> Summary HIV evolved from chimpanzee SIV through zoonotic transmission and became a human pandemic through a combination of viral genetic variability and human behavioral factors. Studying natural SIV hosts reveals that disease is not simply caused by viral load but by immune activation patterns. Cell-to-cell transmission, a mechanism independent of free-floating virus, explains both viral persistence and antiretroviral resistance. Recognizing these mechanisms—from molecular details like glycoprotein cleavage to epidemiological patterns of early spread—provides the foundation for understanding HIV treatment and prevention strategies.